FUNDACIO CENTRE DE REGULACIO GENOMICA
Carrer Doctor Aiguader 88 – Barcelona – 8003
VAT: ESG62426937
http://www.crg.es
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, FUNDACIO CENTRE DE REGULACIO GENOMICA has received € 7,968,430.0 for its participation in a total of 13 project(s) with a total cost of € 219,475,707.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2021-09-01 | 101000309 | 3D-omics | genetics · proteomics · bacteriology · production economics · animal feed | 2025-08-31 | participant | € 670,450.0 | € 10,073,540 | 1 | 13 | CORDIS ↪ |
2019-03-01 | 820431 | LifeTime | drug discovery · history · pathology · machine learning · genomes | 2020-06-30 | participant | € 15,000.0 | € 1,000,000 | 1 | 20 | CORDIS ↪ |
2016-01-01 | 688945 | EuBI PPII | medical and health sciences | 2018-12-31 | participant | € 39,000.0 | € 1,497,910 | 1 | 21 | CORDIS ↪ |
2018-09-01 | 801436 | Hermes SR | fibers · DNA · super resolution microscopy · proteins · stem cells | 2019-08-31 | coordinator | € 11,375.0 | € 100,000 | 1 | 3 | CORDIS ↪ |
2016-02-01 | 686637 | CellViewer | DNA · super resolution microscopy · proteins · software development · stem cells | 2020-09-30 | coordinator | € 2,086,668.26 | € 3,988,752 | 2 | 6 | CORDIS ↪ |
2017-01-01 | 721890 | circRTrain | gene therapy · proteins · oncology · RNA · amyotrophic lateral sclerosis | 2021-09-30 | participant | € 312,595.34 | € 3,865,078 | 1 | 12 | CORDIS ↪ |
2020-01-01 | 874710 | ESPACE | proteomics · diabetes · oncology · enzymes · epigenetics | 2022-06-30 | participant | € 1,162,436.0 | € 4,962,494 | 1 | 11 | CORDIS ↪ |
2021-10-01 | 101034427 | SCREEN4CARE | family planning · genomes | 2026-09-30 | participant | € 389,968.75 | € 25,423,568 | 1 | 37 | CORDIS ↪ |
2019-03-01 | 821558 | IMMUcan | databases · oncology · immunotherapy · microbiology | 2025-08-31 | participant | € 253,941.0 | € 35,779,304 | 1 | 31 | CORDIS ↪ |
2021-09-01 | 964342 | ECaBox | ophthalmology · physiology · transplantation | 2025-08-31 | coordinator | € 1,299,376.25 | € 3,552,143 | 1 | 7 | CORDIS ↪ |
2020-02-01 | 871075 | ELIXIR-CONVERGE | ecosystems | 2023-07-31 | participant | € 246,197.5 | € 9,821,915 | 1 | 57 | CORDIS ↪ |
2015-09-01 | 676559 | ELIXIR-EXCELERATE | 2019-08-31 | participant | € 440,000.0 | € 19,051,482 | 2 | 60 | CORDIS ↪ | |
2019-01-01 | 825575 | EJP RD | ecosystems | 2023-12-31 | participant | € 1,041,424.8 | € 100,359,517 | 2 | 157 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, FUNDACIO CENTRE DE REGULACIO GENOMICA has received € 582,200.0 for its participation in a total of 3 project(s) with a total cost of € 165,346,869.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2024-09-01 | 101156595 | ERDERA | ecosystems | 2031-08-31 | participant | € 70,875.0 | € 145,830,619 | 2 | 178 | CORDIS ↪ |
2023-01-01 | 101096473 | LUCIA | internet of things · lung cancer · sensors · epigenetics · molecular biology | 2026-12-31 | participant | € 0.0 | € 13,516,869 | 4 | 24 | CORDIS ↪ |
2022-06-01 | 101057250 | CANCERNA | melanoma · vaccines · RNA · immunotherapy · leukemia | 2025-05-31 | participant | € 511,325.0 | € 5,999,381 | 6 | 13 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, FUNDACIO CENTRE DE REGULACIO GENOMICA has received € 3,479,133.0 for its participation in a total of 7 project(s) with a total cost of € 96,243,161.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2008-02-01 | 201102 | ONCOMIRS | oncology | 2013-01-31 | participant | € 159,845.6 | € 4,278,007 | 1 | 7 | CORDIS ↪ |
2009-06-01 | 222664 | QUANTOMICS | DNA · dairy · ecosystems · animal husbandry · genomes | 2013-11-30 | participant | € 232,500.8 | € 8,179,086 | 1 | 18 | CORDIS ↪ |
2011-10-01 | 282510 | BLUEPRINT | autoimmune diseases · leukemia · genomes · epigenetics | 2016-09-30 | participant | € 1,761,800.0 | € 39,664,716 | 1 | 45 | CORDIS ↪ |
2010-10-01 | 257082 | EPIGENESYS | epigenetics | 2016-03-31 | participant | € 260,000.0 | € 15,952,636 | 1 | 28 | CORDIS ↪ |
2008-04-01 | 201648 | PROSPECTS | neurobiology · proteomics · cell biology · mass spectrometry · machine learning | 2013-03-31 | participant | € 799,446.0 | € 16,688,081 | 1 | 11 | CORDIS ↪ |
2008-10-01 | 223414 | LEISHDRUG | drug discovery · medicinal chemistry · proteins · pathology | 2012-03-31 | participant | € 229,162.0 | € 4,491,633 | 1 | 13 | CORDIS ↪ |
2010-12-01 | 262023 | EURO-BIOIMAGING | governance · microscopy · diagnostic imaging | 2014-05-31 | participant | € 36,380.0 | € 6,989,000 | 1 | 42 | CORDIS ↪ |